Fitzgerald PB

School of Medicine and Psychology, The Australian National University, Canberra, ACT, Australia.

5 papers · 1 preprint · ORCID

ArticlePsilocybin

No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study.

Bailey NW, Webb SL, Fitzgibbon BM +13

Europe PMC2026
ArticlePsilocybin

Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.

Dutton M, Schwenn P, Mitchell J +5

Europe PMC2026
ArticleKetamine

Ketamine in psychiatry: Ethical imperatives in harnessing a controversial yet promising therapy.

Can AT, Lagopoulos J, Fitzgerald PB +2

Europe PMC2026
PreprintPsilocybin

Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical Population

Fitzgerald PB, Webb SL, Denning NC +12

Europe PMC2025
ArticlePsilocybin

The safety of psilocybin-assisted psychotherapy: A systematic review.

Freitas RR, Gotsis ES, Gallo AT +3

Europe PMC2025
ArticlePsychedelics

The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists.

Berger JJ, Fitzgerald PB

Europe PMC2023